Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02488174 · ClinicalTrials.gov registry record · NA
Prevention of Severe Acute Respiratory Failure in Patients With PROOFCheck
A NA study of Respiratory Failure and Multiple Organ Failure, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 34,040
- Enrollment target
- 3
- Study locations
NCT02488174: Completed NA study of Respiratory Failure and Multiple Organ Failure, sponsored by Albert Einstein College of Medicine.
NCT02488174 is a NA study of Respiratory Failure and Multiple Organ Failure that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 34,040 participants, above the 3,673-participant average among 40 other Respiratory Failure trials with a reported enrollment target (827% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02488174, a NA study of Respiratory Failure and Multiple Organ Failure, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 34,040 participants
- Enrollment target
- 3
- Study locations
Study Summary
Severe acute respiratory failure (ARF) requiring prolonged mechanical ventilation is the most common form of acute organ dysfunction in the hospital, and is often associated with multiple organ failure (MOF), high mortality, and functional impairment. Most studies on ARF have focused on patients in the intensive care unit (ICU) after they have been on mechanical ventilation for days and end organ damage is already established. The overall goal of this proposed project is to improve the outcomes of patients at high risk for developing severe ARF and prolonged mechanical ventilation in and outside of the ICU. The project aims to intervene early in high risk patients with an electronic medical records (EMR)-based, patient-centered checklist of common critical care practices aimed at preventing lung injury and hospital acquired adverse events that commonly lead to organ failure (Prevention of Organ Failure checklist -PROOFcheck). This application proposes a stepped-wedge, clustered randomized control trial to determine the utility of PROOFcheck to improve survival and reduce the duration of mechanical ventilation and multiple organ failure in patients identified as high risk for progressing to severe ARF and prolonged mechanical ventilation. The aims in the UH2 phase are: 1) to refine a previously validated Lung Injury Prediction Score into a pragmatic, EMR-based early prediction model to Accurately Predict Prolonged Ventilation (APPROVE), which will automatically identify patients anywhere in the hospital who are at high risk for developing severe ARF requiring mechanical ventilation \>48 hours; 2) to incorporate PROOFcheck into the EMR to prompt clinicians on care practices to limit lung injury, prevent adverse events, and avoid additional organ failure; and 3) to establish the infrastructure for the proposed trial. The proposed pragmatic trial will harness the hospital-wide EMR to identify patients at high risk for prolonged mechanical ventilation with APPROVE for in
Conditions Studied
Interventions
- OTHER Standard Care
- OTHER PROOFcheck
Study Locations (3)
Florida
- Mayo Clinic - Jacksonville
Minnesota
- Mayo Clinic - Rochester
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34,040 participants |
| Start Date | 2015-08 |
| Est. Completion | 2018-09 |
| Phase | NA |
What the finished NCT02488174 record still lists
NCT02488174 is an interventional study that assigns participants to a tested intervention. Its 34,040 participants enrollment target places it among the larger protocols in the corpus, above the 3,673-participant average among 40 other Respiratory Failure trials with a reported enrollment target (827% higher).
The record links to 2 conditions, with Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which Standard Care is the first listed.
NCT02488174 reports a single indexed study location in Florida, Minnesota, New York.
Frequently Asked Questions
What is clinical trial NCT02488174 about?
NCT02488174 is a clinical study titled "Prevention of Severe Acute Respiratory Failure in Patients With PROOFCheck". Severe acute respiratory failure (ARF) requiring prolonged mechanical ventilation is the most common form of acute organ dysfunction in the hospital, and is often associated with multiple organ failure (MOF), high mortality, and functional impairment. Most studies on ARF have focused on patients in ...
What is the current status of trial NCT02488174?
This trial is currently completed. It is a NA study. The enrollment target is 34,040 participants. The study started on 2015-08. Estimated completion is 2018-09.
What conditions does trial NCT02488174 study?
This clinical trial studies the following conditions: Respiratory Failure, Multiple Organ Failure.
What interventions are being tested in trial NCT02488174?
The interventions under investigation include: Standard Care (OTHER), PROOFcheck (OTHER).
Who is sponsoring clinical trial NCT02488174?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02488174 being conducted?
This trial has 3 study locations across Florida, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02488174's enrollment target sits among peer trials
34,040 2nd of 40 the highest of 40 other Respiratory Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Respiratory Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Analgesia-First Sedation in Trauma Patients
RECRUITING · NA
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Supraglottic Airway for Resuscitation in Preemies
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
A Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03720613 · 34,532 participants
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
- NCT06145724 · 33,183 participants · NA
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
- NCT02225301 · 35,000 participants · NA
iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers
- NCT04477928 · 33,000 participants
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia